People · Operator
Named in public records as an officer, director or promoter · active 2017–2025 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Zetagen Therapeutics, Inc. | — | Pharmaceuticals | Series A | $26.1M | $36.6M | 2017 |
Nikhil Thakur, MD at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Nikhil Thakur, MD on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Peter B. Finn | 1 | 11 |
| Joe C Loy | 1 | 1 |
| Richard C Warburg | 1 | 1 |
| Ashok C Kaveeshwar | 1 | 1 |
| Donald C Brown | 1 | 1 |
| David B. Tischler | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.